{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:56:06Z","timestamp":1791233766257,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03539-8","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:11:32Z","timestamp":1791231092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Controlling Residual Protein Impurities in Active Pharmaceutical Ingredients (APIs) by Derivative Size-Exclusion High-Performance Liquid Chromatography (SEC-HPLC)"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4841-534X","authenticated-orcid":false,"given":"Andrew","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4122-891X","authenticated-orcid":false,"given":"Xiaole","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeena","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heewon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7068-0756","authenticated-orcid":false,"given":"Shanzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"10","key":"3539_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/17460441.2022.2114453","volume":"17","author":"G de Gonzalo","year":"2022","unstructured":"de Gonzalo G, Alc\u00e1ntara AR, Dom\u00ednguez de Mar\u00eda P, S\u00e1nchez-Montero JM. Biocatalysis for the asymmetric synthesis of active pharmaceutical ingredients (APIs): this time is for real. Expert Opin Drug Discov. 2022;17(10):1159\u201371. https:\/\/doi.org\/10.1080\/17460441.2022.2114453.","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"3539_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00044-z","volume":"1","author":"EL Bell","year":"2021","unstructured":"Bell EL, Finnigan W, France SP, Green AP, Hayes MA, Hepworth LJ, et al. Biocatalysis. Nat Rev Methods Primers. 2021;1(1). https:\/\/doi.org\/10.1038\/s43586-021-00044-z.","journal-title":"Nat Rev Methods Primers"},{"issue":"7","key":"3539_CR3","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.bmc.2017.06.043","volume":"26","author":"H Sun","year":"2018","unstructured":"Sun H, Zhang H, Ang EL, Zhao H. Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates. Bioorg Med Chem. 2018;26(7):1275\u201384. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.043.","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"3539_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/biomedicines10050964","volume":"10","author":"A Kinner","year":"2022","unstructured":"Kinner A, Nerke P, Siedentop R, Steinmetz T, Classen T, Rosenthal K, et al. Recent advances in biocatalysis for drug synthesis. Biomedicines. 2022;10(5):964. https:\/\/doi.org\/10.3390\/biomedicines10050964.","journal-title":"Biomedicines"},{"issue":"1","key":"3539_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/catal14010084","volume":"14","author":"N Zhang","year":"2024","unstructured":"Zhang N, Dom\u00ednguez de Mar\u00eda P, Kara S. Biocatalysis for the synthesis of active pharmaceutical ingredients in deep eutectic solvents: state-of-the-art and prospects. Catalysts. 2024;14(1). https:\/\/doi.org\/10.3390\/catal14010084.","journal-title":"Catalysts"},{"issue":"1","key":"3539_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s44371-025-00376-9","volume":"2","author":"DA Undie","year":"2025","unstructured":"Undie DA, Ibekwe FA, Samuel HS, Onotu OP, Akinpelu OO, Etim EE. Biocatalysis in medicinal chemistry: sustainable enzymatic transformations for drug synthesis. Discov Chem. 2025;2(1):335. https:\/\/doi.org\/10.1007\/s44371-025-00376-9.","journal-title":"Discov Chem"},{"issue":"1","key":"3539_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/adsu.202400495","volume":"9","author":"M Khanra","year":"2025","unstructured":"Khanra M, Ravichandiran V, Swain SP. Lipase enzymes for sustainable synthesis of pharmaceuticals and chiral organic building blocks. Adv Sustain Syst. 2025;9(1). https:\/\/doi.org\/10.1002\/adsu.202400495.","journal-title":"Adv Sustain Syst"},{"issue":"1","key":"3539_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s44160-023-00417-0","volume":"3","author":"MT Reetz","year":"2024","unstructured":"Reetz MT, Qu G, Sun Z. Engineered enzymes for the synthesis of pharmaceuticals and other high-value products. Nat Synth. 2024;3(1):19\u201332. https:\/\/doi.org\/10.1038\/s44160-023-00417-0.","journal-title":"Nat Synth"},{"issue":"2","key":"3539_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/01614940.2024.2313603","volume":"67","author":"Q Yuan","year":"2025","unstructured":"Yuan Q, Ma L, Kong W, Liu J, Zhang S, Yan J, et al. Enzymatic synthesis of chiral alcohols using ketoreductases. Catal Rev. 2025;67(2):283\u2013322. https:\/\/doi.org\/10.1080\/01614940.2024.2313603.","journal-title":"Catal Rev"},{"issue":"2","key":"3539_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12257-023-0085-5","volume":"28","author":"TP Khobragade","year":"2023","unstructured":"Khobragade TP, Pagar AD, Giri P, Sarak S, Jeon H, Joo S, et al. Biocatalytic cascade for synthesis of sitagliptin intermediate employing coupled transaminase. Biotechnol Bioprocess Eng. 2023;28(2):300\u20139. https:\/\/doi.org\/10.1007\/s12257-023-0085-5.","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"16","key":"3539_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168557","volume":"25","author":"C Fan","year":"2024","unstructured":"Fan C, Li J, Dong R, Xu Y, Liu L. Investigation of enzyme immobilization and clogging mechanisms in the enzymatic synthesis of amoxicillin. Int J Mol Sci. 2024;25(16). https:\/\/doi.org\/10.3390\/ijms25168557.","journal-title":"Int J Mol Sci"},{"key":"3539_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0003-2670(00)82880-9","volume":"190","author":"J M\u00f6ller","year":"1986","unstructured":"M\u00f6ller J, Hiddessen R, Niehoff J, Sch\u00fcgerl K. On-line high-performance liquid chromatography for monitoring fermentation processes for penicillin production. Anal Chim Acta. 1986;190:195\u2013203. https:\/\/doi.org\/10.1016\/S0003-2670(00)82880-9.","journal-title":"Anal Chim Acta"},{"issue":"7","key":"3539_CR13","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1128\/AEM.02820-06","volume":"73","author":"X Xie","year":"2007","unstructured":"Xie X, Tang Y. Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl Environ Microbiol. 2007;73(7):2054\u201360. https:\/\/doi.org\/10.1128\/AEM.02820-06.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"3539_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1039\/B919115C","volume":"12","author":"SK Ma","year":"2010","unstructured":"Ma SK, Gruber J, Davis C, Newman L, Gray D, Wang A, et al. A green-by-design biocatalytic process for atorvastatin intermediate. Green Chem. 2010;12(1):81\u20136. https:\/\/doi.org\/10.1039\/B919115C.","journal-title":"Green Chem"},{"issue":"1","key":"3539_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1021\/op900272d","volume":"14","author":"J Liang","year":"2010","unstructured":"Liang J, Lalonde J, Borup B, Mitchell V, Mundorff E, Trinh N, et al. Development of a biocatalytic process as an alternative to the (-)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast. Org Process Res Dev. 2010;14(1):193\u20138. https:\/\/doi.org\/10.1021\/op900272d.","journal-title":"Org Process Res Dev"},{"issue":"9","key":"3539_CR16","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1039\/D4OB02047B","volume":"23","author":"E de Prado","year":"2025","unstructured":"de Prado E, Mangas-S\u00e1nchez J, Gotor-Fern\u00e1ndez V. Chemoenzymatic synthesis of tamsulosin. Org Biomol Chem. 2025;23(9):2244\u201353. https:\/\/doi.org\/10.1039\/D4OB02047B.","journal-title":"Org Biomol Chem"},{"issue":"11-12","key":"3539_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/adsc.201100488","volume":"353","author":"CA Busacca","year":"2011","unstructured":"Busacca CA, Fandrick DR, Song JJ, Senanayake CH. The growing impact of catalysis in the pharmaceutical industry. Adv Synth Catal. 2011;353(11\u201312):1825\u201364. https:\/\/doi.org\/10.1002\/adsc.201100488.","journal-title":"Adv Synth Catal"},{"issue":"4","key":"3539_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/bit.70154","volume":"123","author":"J Graham","year":"2026","unstructured":"Graham J, Anand SS, Bercu J, Besenhofer L, de Zafra C, Feng Y, et al. Assessment and control of host cell proteins in biologics: survey of industry practices and a vision for harmonization. Biotechnol Bioeng. 2026;123(4):1050\u201363. https:\/\/doi.org\/10.1002\/bit.70154.","journal-title":"Biotechnol Bioeng"},{"issue":"11","key":"3539_CR19","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1002\/bit.70029","volume":"122","author":"L Coye","year":"2025","unstructured":"Coye L, Jones MA, Gaza-Bulseco G, Chitikila C, Clavier S, Fougeron D, et al. Host cell protein clinical safety risk assessment-an updated industry review. Biotechnol Bioeng. 2025;122(11):3229\u201348. https:\/\/doi.org\/10.1002\/bit.70029.","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"3539_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/elsc.202200060","volume":"23","author":"Y Lu","year":"2023","unstructured":"Lu Y, Lin J, Bian T, Chen J, Liu D, Ma M, et al. Risk control of host cell proteins in one therapeutic antibody produced by concentrated fed-batch (CFB) mode. Eng Life Sci. 2023;23(3). https:\/\/doi.org\/10.1002\/elsc.202200060.","journal-title":"Eng Life Sci"},{"key":"3539_CR21","doi-asserted-by":"publisher","unstructured":"Lee H, editor. Pharmaceutical industry practices on genotoxic impurities. 1st ed. Boca Raton (FL): CRC Press; 2014. (Chromatographic Science Series; vol. 107). https:\/\/doi.org\/10.1201\/b17350","DOI":"10.1201\/b17350"},{"issue":"3","key":"3539_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1021\/acs.oprd.5b00369","volume":"20","author":"AS Wells","year":"2016","unstructured":"Wells AS, Wong JW, Michels PC, Entwistle DA, Fandrick K, Finch GL, et al. Case studies illustrating a science and risk-based approach to ensuring drug quality when using enzymes in the manufacture of active pharmaceuticals ingredients for oral dosage form. Org Process Res Dev. 2016;20(3):594\u2013601. https:\/\/doi.org\/10.1021\/acs.oprd.5b00369.","journal-title":"Org Process Res Dev"},{"issue":"8","key":"3539_CR23","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/bit.28112","volume":"119","author":"F Wang","year":"2022","unstructured":"Wang F, Li X, Swanson M, Guetschow E, Winston M, Smith JP, et al. Holistic analytical characterization and risk assessment of residual host cell protein impurities in an active pharmaceutical ingredient synthesized by biocatalysts. Biotechnol Bioeng. 2022;119(8):2088\u2013104. https:\/\/doi.org\/10.1002\/bit.28112.","journal-title":"Biotechnol Bioeng"},{"key":"3539_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114393","volume":"207","author":"JP Smith","year":"2022","unstructured":"Smith JP, Ralbovsky NM, Lauro ML, Hoyt E, Guetschow ED, Wang F, et al. Quantitation and speciation of residual protein within active pharmaceutical ingredients using image analysis with SDS-PAGE. J Pharm Biomed Anal. 2022;207. https:\/\/doi.org\/10.1016\/j.jpba.2021.114393.","journal-title":"J Pharm Biomed Anal"},{"issue":"16","key":"3539_CR25","doi-asserted-by":"publisher","first-page":"8879","DOI":"10.1021\/acs.jafc.3c09188","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Bednarcik M, Ament C, Cheever ML, Cummings S, Geng T, et al. Immunoassays and mass spectrometry for determination of protein concentrations in genetically modified crops. J Agric Food Chem. 2024;72(16):8879\u201389. https:\/\/doi.org\/10.1021\/acs.jafc.3c09188.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"3539_CR26","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02457-9","volume":"24","author":"SN Telikepalli","year":"2023","unstructured":"Telikepalli SN, Carrier MJ, Ripple DC, Barnett G, Bhirde A, Bolton D, et al. An interlaboratory study to identify potential visible protein-like particle standards. AAPS PharmSciTech. 2023;24(1). https:\/\/doi.org\/10.1208\/s12249-022-02457-9.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"3539_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/acs.oprd.2c00327","volume":"27","author":"MS Winston","year":"2023","unstructured":"Winston MS, Poirier M, Liu Z, Peng F, Humphrey GR, McIntosh JA, et al. pH-switchable phase-transfer agents for host cell protein rejection in the cascaded biocatalytic synthesis of an active pharmaceutical ingredient. Org Process Res Dev. 2023;27(1):179\u201388. https:\/\/doi.org\/10.1021\/acs.oprd.2c00327.","journal-title":"Org Process Res Dev"},{"issue":"1","key":"3539_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.14","volume":"1","author":"H Jiang","year":"2021","unstructured":"Jiang H, Cole PA. N-terminal protein labeling with N-hydroxysuccinimide esters and microscale thermophoresis measurements of protein-protein interactions using labeled protein. Curr Protoc. 2021;1(1). https:\/\/doi.org\/10.1002\/cpz1.14.","journal-title":"Curr Protoc"},{"issue":"3","key":"3539_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031083","volume":"28","author":"A Tantipanjaporn","year":"2023","unstructured":"Tantipanjaporn A, Wong MK. Development and recent advances in lysine and N-terminal bioconjugation for peptides and proteins. Molecules. 2023;28(3). https:\/\/doi.org\/10.3390\/molecules28031083.","journal-title":"Molecules"},{"key":"3539_CR30","doi-asserted-by":"publisher","unstructured":"Booth BP, Simon WC. Analytical method validation. In: Sahajwalla C, editor. New drug development: regulatory paradigms for clinical pharmacology and biopharmaceutics. Boca Raton (FL): CRC Press; 2004. p. 167\u201388. https:\/\/doi.org\/10.1201\/9780203026427-15.","DOI":"10.1201\/9780203026427-15"},{"issue":"18","key":"3539_CR31","doi-asserted-by":"publisher","first-page":"9976","DOI":"10.1021\/acs.analchem.7b02329","volume":"89","author":"DSH Chan","year":"2017","unstructured":"Chan DSH, Kavanagh ME, McLean KJ, Munro AW, Matak-Vinkovi\u0107 D, Coyne AG, et al. Effect of DMSO on protein structure and interactions assessed by collision-induced dissociation and unfolding. Anal Chem. 2017;89(18):9976\u201383. https:\/\/doi.org\/10.1021\/acs.analchem.7b02329.","journal-title":"Anal Chem"},{"issue":"11","key":"3539_CR32","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/cphc.201300313","volume":"14","author":"A Pabbathi","year":"2013","unstructured":"Pabbathi A, Patra S, Samanta A. Structural transformation of bovine serum albumin induced by dimethyl sulfoxide and probed by fluorescence correlation spectroscopy and additional methods. ChemPhysChem. 2013;14(11):2441\u20139. https:\/\/doi.org\/10.1002\/cphc.201300313.","journal-title":"ChemPhysChem"},{"issue":"2","key":"3539_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0006-291X(05)80083-X","volume":"173","author":"K Hirayama","year":"1990","unstructured":"Hirayama K, Akashi S, Furuya M, Fukuhara K. Rapid confirmation and revision of the primary structure of bovine serum albumin by ESIMS and frit-FAB LC\/MS. Biochem Biophys Res Commun. 1990;173(2):639\u201346. https:\/\/doi.org\/10.1016\/S0006-291X(05)80083-X.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"3539_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.top099242","volume":"2020","author":"EA Berg","year":"2020","unstructured":"Berg EA, Fishman JB. Labeling antibodies. Cold Spring Harb Protoc. 2020;2020(7). https:\/\/doi.org\/10.1101\/pdb.top099242.","journal-title":"Cold Spring Harb Protoc"},{"issue":"1","key":"3539_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/mps1010002","volume":"1","author":"I Abbas","year":"2018","unstructured":"Abbas I, Schwaar T, Bienwald F, Weller M. Predictable peptide conjugation ratios by activation of proteins with succinimidyl iodoacetate (SIA). Methods Protoc. 2018;1(1). https:\/\/doi.org\/10.3390\/mps1010002.","journal-title":"Methods Protoc"},{"issue":"18","key":"3539_CR36","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/cbic.201700210","volume":"18","author":"R Dasari","year":"2017","unstructured":"Dasari R, La Clair JJ, Kornienko A. Irreversible protein labeling by Paal-Knorr conjugation. ChemBioChem. 2017;18(18):1792\u20136. https:\/\/doi.org\/10.1002\/cbic.201700210.","journal-title":"ChemBioChem"},{"issue":"1","key":"3539_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07706-2","volume":"12","author":"L Reimer","year":"2022","unstructured":"Reimer L, Haikal C, Gram H, Theologidis V, Kovacs G, Ruesink H, et al. Low-dose DMSO treatment induces oligomerization and accelerates aggregation of \u03b1-synuclein. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-07706-2.","journal-title":"Sci Rep"},{"key":"3539_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-1-4939-6887-9_17","volume":"1586","author":"JD Love","year":"2017","unstructured":"Love JD. Expression of prokaryotic integral membrane proteins in E. coli. Methods Mol Biol. 2017;1586:265\u201378. https:\/\/doi.org\/10.1007\/978-1-4939-6887-9_17.","journal-title":"Methods Mol Biol"},{"issue":"11","key":"3539_CR39","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1021\/jp911720w","volume":"114","author":"X Qin","year":"2010","unstructured":"Qin X, Liu M, Yang D, Zhang X. Concentration-dependent aggregation of CHAPS investigated by NMR spectroscopy. J Phys Chem B. 2010;114(11):3863\u20138. https:\/\/doi.org\/10.1021\/jp911720w.","journal-title":"J Phys Chem B"},{"issue":"14","key":"3539_CR40","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1021\/jp501729s","volume":"118","author":"FE Herrera","year":"2014","unstructured":"Herrera FE, Garay AS, Rodrigues DE. Structural properties of CHAPS micelles, studied by molecular dynamics simulations. J Phys Chem B. 2014;118(14):3912\u201321. https:\/\/doi.org\/10.1021\/jp501729s.","journal-title":"J Phys Chem B"},{"issue":"27","key":"3539_CR41","doi-asserted-by":"publisher","first-page":"10268","DOI":"10.1021\/acssuschemeng.5c01094","volume":"13","author":"J Colberg","year":"2025","unstructured":"Colberg J, Tucker JL, Mart\u00ednez I, Bailey JD, Briddell C, Koenig SG,et al. Environmental sustainability strategy of active pharmaceutical ingredient manufacturing: a perspective from the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable. ACS Sustain Chem Eng. 2025;13(27):10268\u201384. https:\/\/doi.org\/10.1021\/acssuschemeng.5c01094.","journal-title":"ACS Sustain Chem Eng"},{"issue":"7397","key":"3539_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature11117","volume":"485","author":"UT Bornscheuer","year":"2012","unstructured":"Bornscheuer UT, Huisman GW, Kazlauskas RJ, Lutz S, Moore JC, Robins K. Engineering the third wave of biocatalysis. Nature. 2012;485(7397):185\u201394. https:\/\/doi.org\/10.1038\/nature11117.","journal-title":"Nature"},{"issue":"5","key":"3539_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27052444","volume":"27","author":"JM Fern\u00e1ndez-Ca\u00f1\u00f3n","year":"2026","unstructured":"Fern\u00e1ndez-Ca\u00f1\u00f3n JM, Chamizo-Ampudia A. Toward sustainable testosterone manufacturing: green chemistry and microbial biotransformation approaches. Int J Mol Sci. 2026;27(5). https:\/\/doi.org\/10.3390\/ijms27052444.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3539_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56612-7","volume":"9","author":"DP Gavin","year":"2019","unstructured":"Gavin DP, Reen FJ, Rocha-Martin J, Abreu-Castilla I, Woods DF, Foley AM, et al. Genome mining and characterisation of a novel transaminase with remote stereoselectivity. Sci Rep. 2019;9(1). https:\/\/doi.org\/10.1038\/s41598-019-56612-7.","journal-title":"Sci Rep"},{"key":"3539_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145585","volume":"320","author":"Q Li","year":"2025","unstructured":"Li Q, Li L, Hu D, Lu Z, He YC, Ma C. Multi-enzyme system for efficient bioamination of lignin-derived vanillin into vanillylamine: enzyme structural insights and pyruvate removal strategy for enhanced biocatalytic performance. Int J Biol Macromol. 2025;320. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145585.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"3539_CR46","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1021\/acscatal.5c06313","volume":"16","author":"A Miletic","year":"2026","unstructured":"Miletic A, Truby CJ, Turner NJ, Ruscoe RE. Alcohol oxidase-imine reductase cascade for one-pot chiral amine synthesis. ACS Catal. 2026;16(3):2119\u201323. https:\/\/doi.org\/10.1021\/acscatal.5c06313.","journal-title":"ACS Catal"},{"issue":"6","key":"3539_CR47","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1021\/acscatal.5c09322","volume":"16","author":"W Gao","year":"2026","unstructured":"Gao W, Jin Y, Liu C, Liu X, Jia X, Qu X, et al. Chemoenzymatic synthesis of unnatural ergot alkaloid, demethyl chanoclavine. ACS Catal. 2026;16(6):5457\u201365. https:\/\/doi.org\/10.1021\/acscatal.5c09322.","journal-title":"ACS Catal"},{"issue":"3","key":"3539_CR48","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1021\/acscatal.4c07464","volume":"15","author":"W Fu","year":"2025","unstructured":"Fu W, Liu A, Yang Y. Diastereo- and enantioselective chemoenzymatic synthesis of chiral tricyclic intermediate of anti-HIV drug lenacapavir. ACS Catal. 2025;15(3):2045\u201352. https:\/\/doi.org\/10.1021\/acscatal.4c07464.","journal-title":"ACS Catal"},{"issue":"6","key":"3539_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s11095-022-03457-x","volume":"40","author":"NM Ralbovsky","year":"2023","unstructured":"Ralbovsky NM, Smith JP. Machine learning for prediction, classification, and identification of immobilized enzymes for biocatalysis. Pharm Res. 2023;40(6):1479\u201390. https:\/\/doi.org\/10.1007\/s11095-022-03457-x.","journal-title":"Pharm Res"},{"issue":"4","key":"3539_CR50","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1021\/acscatal.4c06207","volume":"15","author":"J Planas-Iglesias","year":"2025","unstructured":"Planas-Iglesias J, Majerova M, Pluskal D, Vasina M, Damborsky J, Prokop Z, et al. Automated engineering protein dynamics via loop grafting: improving Renilla luciferase catalysis. ACS Catal. 2025;15(4):3391\u2013404. https:\/\/doi.org\/10.1021\/acscatal.4c06207.","journal-title":"ACS Catal"},{"issue":"39","key":"3539_CR51","doi-asserted-by":"publisher","first-page":"45886","DOI":"10.1021\/acsami.3c09123","volume":"15","author":"W Zhang","year":"2023","unstructured":"Zhang W, Dong H, Wang X, Zhang L, Chen C, Wang P. Engineered Escherichia coli consortia function in a programmable pattern for multiple enzymatic biosynthesis. ACS Appl Mater Interfaces. 2023;15(39):45886\u201394. https:\/\/doi.org\/10.1021\/acsami.3c09123.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"3539_CR52","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1007\/s00253-015-7200-2","volume":"100","author":"FJ Zhao","year":"2016","unstructured":"Zhao FJ, Pei XQ, Ren ZQ, Wu ZL. Rapid asymmetric reduction of ethyl 4-chloro-3-oxobutanoate using a thermostabilized mutant of ketoreductase ChKRED20. Appl Microbiol Biotechnol. 2016;100(8):3567\u201375. https:\/\/doi.org\/10.1007\/s00253-015-7200-2.","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03539-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:11:33Z","timestamp":1791231093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03539-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3539"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03539-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FY, XS, CQ, ZW, and HL are employees of Boehringer Ingelheim Inc. (CT, USA). AR and SW have no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"323"}}